Submit a comment

Edg-1, the G protein–coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation
Yujing Liu, Ryuichi Wada, Tadashi Yamashita, Yide Mi, Chu-Xia Deng, John P. Hobson, Hans M. Rosenfeldt, Victor E. Nava, Sung-Suk Chae, Menq-Jer Lee, Catherine H. Liu, Timothy Hla, Sarah Spiegel, Richard L. Proia
Yujing Liu, Ryuichi Wada, Tadashi Yamashita, Yide Mi, Chu-Xia Deng, John P. Hobson, Hans M. Rosenfeldt, Victor E. Nava, Sung-Suk Chae, Menq-Jer Lee, Catherine H. Liu, Timothy Hla, Sarah Spiegel, Richard L. Proia
View: Text | PDF
Article

Edg-1, the G protein–coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation

Abstract

Sphingolipid signaling pathways have been implicated in many critical cellular events. Sphingosine-1-phosphate (SPP), a sphingolipid metabolite found in high concentrations in platelets and blood, stimulates members of the endothelial differentiation gene (Edg) family of G protein–coupled receptors and triggers diverse effects, including cell growth, survival, migration, and morphogenesis. To determine the in vivo functions of the SPP/Edg signaling pathway, we disrupted the Edg1 gene in mice. Edg1–/– mice exhibited embryonic hemorrhage leading to intrauterine death between E12.5 and E14.5. Vasculogenesis and angiogenesis appeared normal in the mutant embryos. However, vascular maturation was incomplete due to a deficiency of vascular smooth muscle cells/pericytes. We also show that Edg-1 mediates an SPP-induced migration response that is defective in mutant cells due to an inability to activate the small GTPase, Rac. Our data reveal Edg-1 to be the first G protein–coupled receptor required for blood vessel formation and show that sphingolipid signaling is essential during mammalian development.

Authors

Yujing Liu, Ryuichi Wada, Tadashi Yamashita, Yide Mi, Chu-Xia Deng, John P. Hobson, Hans M. Rosenfeldt, Victor E. Nava, Sung-Suk Chae, Menq-Jer Lee, Catherine H. Liu, Timothy Hla, Sarah Spiegel, Richard L. Proia

×

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

  • Comments appear on the Journal’s website and are linked from the original article’s web page.
  • Authors are notified by email if their comments are posted.
  • The Journal reserves the right to edit comments for length and clarity.
  • No appeals will be considered.
  • Comments are not indexed in PubMed.

Specific requirements

  • Maximum length, 400 words
  • Entered as plain text or HTML
  • Author’s name and email address, to be posted with the comment
  • Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
  • Comments may not include figures
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required